Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases
Ali Theibich(Gentofte Hospital), Henning Locht(Frederiksberg Hospital), Melinda Magyari(University of Copenhagen), Lene Dreyer(Institute for Rheumatic Diseases (Japan))
Cited by 53
Related Papers
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209
Comorbidity in Multiple Sclerosis
|Frontiers in Neurology|2020|204